http://yahoo.reuters.com/financeQuoteCompanyNewsArticle.jhtml?duid=mtfh90634_2005-09-28_01-02-58_n27201175_newsmlA key Genentech Inc. (DNA.N: Quote, Profile, Research) patent covering the production of antibody drugs has been rejected by the U.S. patent office, sending the company's shares down 3.3 percent on Tuesday.
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar.